"I now know how cancer can strike anyone whatever their situation or circumstance. I hope by taking part in a trial it will help others in my position in the future.”
A study looking at a rehabilitation programme for men who have completed treatment for testicular cancer (RESTART)
This study tested a 6 week programme to give men advice and support after treatment for testicular cancer.
This study was open for men to join between January and November 2012. These results were presented as a poster at a conference in 2013.
More about this trial
Cancer and its treatment can have physical, psychological and financial effects. Of the people who do return to work after treatment, some find they can’t do as much as they could before.
Despite this most survivors of testicular cancer say they have a more positive outlook on life after their diagnosis. We also know from research that survivors of testicular cancer have a good quality of life in general.
Programmes to support people after cancer treatment (
Researchers in this study ran a rehabilitation programme for men who had finished treatment to cure their cancer. It gave specialist advice and support about returning to work, finance, exercise, relationships and fertility.
Other similar programmes have been helpful for people with other cancers.
The aim of this pilot study was to test a rehabilitation programme for testicular cancer and use the results to improve the programme.
Summary of results
- well received by the men
- feasible to do
- at the start of the programme
- after the end of the programme
- their anxiety
quality of life
- side effects
- how they managed their cancer
- being able to better manage their cancer
- feeling better about the future
- that the impact of the treatment’s side effects had decreased
- reduce anxiety and depression
- improve quality of life
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jeff White
Macmillan Cancer Support
NHS Greater Glasgow and Clyde
NIHR Clinical Research Network: Cancer